How can CV outcomes trials in T2D guide clinical practice?

An expert panel offers practical insights.
Sponsored
0
27 August 2021
Save

This content has been independently produced by ADG, made possible through sponsorship from Eli Lilly.

Cardiovascular disease is the leading cause of death in people with type 2 diabetes, so addressing cardiovascular risk is a vital part of diabetes care.

Report

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Content that breaches the privacy of other individuals
Contains spam, fake content or potential malware

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .